<http://webisa.webdatacommons.org/230309948>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<medpagetoday.com> .
<http://webisa.webdatacommons.org/230309948>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .
<http://webisa.webdatacommons.org/prov/431132603>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/230309948> .
<http://webisa.webdatacommons.org/prov/436841091>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/230309948> .
<http://webisa.webdatacommons.org/230309948>	<http://www.w3.org/ns/prov#value>	"This marker was then tested in a separate sample of 31 FTLD-TDP patients, 19 with FTLD-tau, 10 normal controls, and 26 with Alzheimer's disease or other neurological diseases." .